Our laboratory focuses on understanding the molecular and cellular mechanisms underlying adult / congenital cardiovascular diseases and developing new approaches to improve cardiovascular recovery, mainly utilizing cardiac progenitor cells (CPC) and induced pluripotent stem cells (iPSC) for disease modelling and cell therapeutics. We are also particularly interested in defining the therapeutic and diagnostic potential of extracellular vesicles (EVs) in cardiogenesis, cardiac regeneration and progression of cardiovascular diseases.